Teva Pharmaceuticals USA Inc. v. Dr Reddy's Laboratories Ltd
1:14-cv-01172
Overview
Parties
Defendant
Dr Reddy's Laboratories Ltd Operating Company
Represented By
5 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Teva Pharmaceutical Industries Ltd Operating Company
Represented By
2 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Teva Pharmaceuticals USA Inc. Operating Company
Represented By
9 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Plaintiff
Yeda Research and Development Co Ltd. Operating Company
Represented By
2 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Teva Neuroscience Inc Operating Company
Represented By
2 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Counter Claimant
Dr Reddy's Laboratories Inc. Operating Company
Represented By
2 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 8,232,250 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 27,468,709 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 33,761,210 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,399,413 B2 | US Continuation / Sibling | View Official Patent → |
Amneal Pharmaceuticals LLC v. Yeda Research & Development Co., Ltd. et al.
Amneal Pharmaceuticals LLC v. YEDA RESEARCH & DEVELOPMENT CO. LTD. et al.
Mylan Pharmaceuticals Inc. et al. v. Yeda Research and Development Co. Ltd. et al.
Mylan Pharmaceuticals Inc. et al. v. Yeda Research and Development Co. Ltd. et al.
Teva Pharmaceuticals USA Inc. v. Amneal Pharmaceuticals LLC
Teva Pharmaceuticals USA Inc. v. Synthon Pharmaceuticals, Inc.
Teva Pharmaceuticals USA Inc. v. Mylan Pharmaceuticals Inc.
In Re Copaxone 40 MG Consolidated Cases
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8232250
Low frequency glatiramer acetate therapy
|
Filed: 2011-11-30
Issued: 2012-07-31
|
Active (5.0 yrs remaining)
Expires: 2031-11-30
|
|
|
US8399413
Low frequency glatiramer acetate therapy
|
Filed: 2010-08-19
Issued: 2013-03-19
|
Active (3.8 yrs remaining)
+18d PTA
Expires: 2030-09-06
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
2
Dispositive
0
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings